(R)-2-((tert-Butoxycarbonyl)amino)-6-ureidohexanoic acid, 95.0%, 5g

3,6-DI-O-TERT-BUTYLDIMETHYLSILYL-D-GLUCAL, 95.0%, 5g

5-[4-(methylthio)benzyl]-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

6-Phenyl-3,4-dihydrothieno[3,2-d]pyrimidin-4-one, 1g

Triacontane>98.0%(GC)5g

1-(3-Fluoro-2-methylbenzyl)piperidin-4-amine dihydrochloride, 95.0%, 1g

Monohidrato de ácido gálico, mínimo 98 %, pa, ACS, 100 g, envase de plástico.

1-(4-Chlorobenzyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 250mg

Silver Behenate>95.0%(T)25g

1-(4-Chlorophenyl)-3,5-dimethyl-1H-pyrazole-4-carbonitrile, 95.0%, 1g

2-Methylthiophen-3-amine hydrochloride, 95+%, 100mg

(S)-Methyl 4-benzylmorpholine-3-carboxylate, 95.0%, 100mg

Methyl 4-hydroxypiperidine-4-carboxylate hydrochloride, 95.0%, 1g